Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone
- PMID: 26393791
- PMCID: PMC4578942
- DOI: 10.1371/journal.pone.0138189
Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone
Abstract
The cytokine receptor activator of nuclear factor kappa B ligand (RANKL), encoded by the Tnfsf11 gene, is essential for osteoclastogenesis and previous studies have shown that deletion of the Tnfsf11 gene using a Dmp1-Cre transgene reduces osteoclast formation in cancellous bone by more than 70%. However, the Dmp1-Cre transgene used in those studies leads to recombination in osteocytes, osteoblasts, and lining cells making it unclear whether one or more of these cell types produce the RANKL required for osteoclast formation in cancellous bone. Because osteoblasts, osteocytes, and lining cells have distinct locations and functions, distinguishing which of these cell types are sources of RANKL is essential for understanding the orchestration of bone remodeling. To distinguish between these possibilities, we have now created transgenic mice expressing the Cre recombinase under the control of regulatory elements of the Sost gene, which is expressed in osteocytes but not osteoblasts or lining cells in murine bone. Activity of the Sost-Cre transgene in osteocytes, but not osteoblast or lining cells, was confirmed by crossing Sost-Cre transgenic mice with tdTomato and R26R Cre-reporter mice, which express tdTomato fluorescent protein or LacZ, respectively, only in cells expressing the Cre recombinase or their descendants. Deletion of the Tnfsf11 gene in Sost-Cre mice led to a threefold decrease in osteoclast number in cancellous bone and increased cancellous bone mass, mimicking the skeletal phenotype of mice in which the Tnfsf11 gene was deleted using the Dmp1-Cre transgene. These results demonstrate that osteocytes, not osteoblasts or lining cells, are the main source of the RANKL required for osteoclast formation in remodeling cancellous bone.
Conflict of interest statement
Figures
Similar articles
-
Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.PLoS One. 2012;7(6):e40143. doi: 10.1371/journal.pone.0040143. Epub 2012 Jun 29. PLoS One. 2012. PMID: 22768243 Free PMC article.
-
Activation of Notch3 in osteoblasts/osteocytes causes compartment-specific changes in bone remodeling.J Biol Chem. 2021 Jan-Jun;296:100583. doi: 10.1016/j.jbc.2021.100583. Epub 2021 Mar 24. J Biol Chem. 2021. PMID: 33774049 Free PMC article.
-
PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.J Bone Miner Res. 2011 May;26(5):1035-46. doi: 10.1002/jbmr.304. J Bone Miner Res. 2011. PMID: 21140374 Free PMC article.
-
Regulatory mechanisms of RANKL presentation to osteoclast precursors.Curr Osteoporos Rep. 2014 Mar;12(1):115-20. doi: 10.1007/s11914-014-0189-0. Curr Osteoporos Rep. 2014. PMID: 24477414 Review.
-
Osteocyte RANKL: new insights into the control of bone remodeling.J Bone Miner Res. 2012 Mar;27(3):499-505. doi: 10.1002/jbmr.1547. J Bone Miner Res. 2012. PMID: 22354849 Free PMC article. Review.
Cited by
-
TGF-β signaling in the cranial neural crest affects late-stage mandibular bone resorption and length.Front Physiol. 2024 Oct 15;15:1435594. doi: 10.3389/fphys.2024.1435594. eCollection 2024. Front Physiol. 2024. PMID: 39473613 Free PMC article.
-
Lophatherum gracile Bronghiart Suppresses Receptor Activator of Nuclear Factor Kappa-B Ligand-Stimulated Osteoclastogenesis and Prevents Ovariectomy-Induced Osteoporosis.Int J Mol Sci. 2022 Nov 11;23(22):13942. doi: 10.3390/ijms232213942. Int J Mol Sci. 2022. PMID: 36430416 Free PMC article.
-
Cellular and Molecular Pathways Leading to External Root Resorption.J Dent Res. 2017 Feb;96(2):145-152. doi: 10.1177/0022034516677539. Epub 2016 Nov 5. J Dent Res. 2017. PMID: 27811065 Free PMC article. Review.
-
Parathyroid Hormone Signaling in Osteocytes.JBMR Plus. 2017 Nov 10;2(1):22-30. doi: 10.1002/jbm4.10021. eCollection 2018 Jan. JBMR Plus. 2017. PMID: 30283888 Free PMC article. Review.
-
Recent Trends in Hydroxyapatite Supplementation for Osteoregenerative Purposes.Materials (Basel). 2023 Feb 3;16(3):1303. doi: 10.3390/ma16031303. Materials (Basel). 2023. PMID: 36770309 Free PMC article. Review.
References
-
- Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165–76. - PubMed
-
- Fata JE, Kong YY, Li J, Sasaki T, Irie-Sasaki J, Moorehead RA, et al. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 2000;103:41–50. - PubMed
-
- Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999;397:315–23. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
